ReviewDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy2026
Novel quinoxaline-based survivin degraders overcome docetaxel-resistance in castration-resistant prostate cancer.
Caoqinglong Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.